Zusammenfassung
Hintergrund
Untersuchungen zeigen, dass Patienten ohne Regionalanalgesieverfahren oder patientenkontrolliertes i.v.-Analgesieverfahren (PCIA) nach Operationen oft unter zu starken Schmerzen leiden. Ziel dieser prospektiven Observationsstudie war es, die Wirksamkeit und Durchführbarkeit eines einfachen und an den Bedarf des Patienten anpassbaren oralen Therapiealgorithmus für diese Patienten zu evaluieren.
Material und Methoden
Patienten, die routinemäßig nach elektiven unfall- (UCH) oder allgemeinchirurgischen (ACH) und Hals-Nasen-Ohrenheilkunde(HNO)-Eingriffen nach einem Therapiealgorithmus behandelt wurden, der eine Basisanalgesie (orales retardiertes Opioid plus Nichtopioidanalgetikum) und ein Bedarfsanalgetikum (nichtretardiertes orales Opioid) umfasste, wurden nach Einwilligung in die Studie eingeschlossen. Sowohl präoperativ als auch für 4 Tage postoperativ wurden standardisiert demografische Daten einschließlich der präoperativen Schmerzen und des Analgetikaverbrauchs sowie ergebnisbezogene Daten wie Schmerzintensität, Übelkeit, Erbrechen, Zufriedenheit mit der Schmerztherapie und Gründe für Unzufriedenheit erhoben. Sechs und 12 Monate nach Operation wurden die aktuellen Schmerzen und die Lebensqualität evaluiert.
Ergebnisse
Insgesamt wurden 275 Patienten in die Studie eingeschlossen (HNO: n = 163; UCH: n = 82; ACH: n = 30). Die Schmerzintensität in Ruhe lag bei ≤ 3 (median) für alle Patienten; Belastungsschmerzen lagen bei ≤ 4 in der HNO- und bei ≤ 5 in der ACH- bzw. UCH-Gruppe. In der HNO und ACH war der Basisanalgetikaverbrauch (retardiertes Opioid) signifikant geringer als in der UCH (p < 0,001). Die häufigsten Nebenwirkungen waren Übelkeit, Erbrechen und Obstipation; während Obstipation deutlich häufiger bei Patienten in der ACH und in der UCH auftrat als in der HNO, konnte kein Unterschied hinsichtlich Übelkeit und Erbrechen gefunden werden. Es wurden keine schwerwiegenden unerwünschten Nebenwirkungen beobachtet. Depressive Patienten litten unter stärkeren akuten postoperativen Schmerzen. Von den Patienten, die Rückmeldung gaben, berichteten 11 (15,7%) bzw. 7 (14,9%) über persistierende postoperative Schmerzen 6 bzw. 12 Monate nach Operation.
Schlussfolgerung
Mit dieser Studie konnten wir zeigen, dass die Implementierung und Anwendung eines opioidbasierten Therapiealgorithmus für Patienten ohne PCIA effektiv in der Behandlung postoperativer Schmerzen ist. Patienten nach UCH-Eingriffen benötigten signifikant mehr Basisanalgetika als Patienten der HNO oder ACH bei gleicher Inzidenz potenzieller opioidassoziierter Nebenwirkungen, ausgenommen Obstipation.
Abstract
Background
Postoperative pain continues to be undermanaged, at least in part, due to inadequate organization and lack of use of opioids. Especially patients who do not receive consultation from an acute pain service and are therefore not eligible to receive regional anesthesia techniques or patient-controlled devices suffer from severe pain after surgery. The aim of the present prospective observational study was to assess the efficacy and feasibility of an analgesia algorithm for this subgroup of patients.
Methods
An oral opioid concept including controlled-release (cr) oxycodone, immediate-release (ir) hydromorphone and a non-opioid analgesic was implemented at three different departments at the University Clinic of Muenster, Germany. Briefly, cr-oxycodon was administered preoperatively to patients undergoing ear nose and throat (ENT), general or elective trauma surgery on the day of surgery and every 12 h for a maximum of 4 days postoperatively. Inadequately managed pain above 3 on a visual analog scale (VAS 0–10) at rest and above 5 during movement was treated with ir-hydromorphone on patient request. After written informed consent, patients were assessed prospectively for up to 5 days perioperatively using a standardized questionnaire preoperatively, for 4 days postoperatively as well as 6 and 12 months after surgery.
Results
A total of 275 patients were included in the present prospective observational study: (ENT surgery: 163, trauma surgery 82 and general surgery 30). Median resting and evoked numeric rating scale (NRS) pain scores were equal or less than 3 and 5, respectively. Less patients received cr-oxycodone after ENT and general surgery compared to trauma surgery (p < 0.001). Constipation was more frequent after general and trauma surgery compared to ENT surgery. Vomiting decreased from 20 %-30 % on the day of surgery to 10 % or less regardless of the type of operation. No severe adverse events were observed. Additionally, patients with an increased depression score before surgery reported greater immediate postoperative pain than non-depressed patients. Of the patients 11 (15.7 %) and 7 (14.9 %) complained about persistent postoperative pain 6 and 12 months after surgery, respectively and these patients had increased acute pain ratings during the first postoperative days.
Conclusions
The present study has demonstrated that the implementation of an oral opioid algorithm for patients without patient-controlled intravenous or regional analgesia is effective and feasible on surgical wards. Patients who underwent trauma surgery needed more cr-oxycodone. Side effects were similar regardless of the operation with the exception of obstipation which was more frequent after trauma and general surgery compared to ENT surgery.
Literatur
Apfelbaum JL, Chen C, Mehta SS et al (2003) Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 97:534–540
Blumenthal S, Min K, Marquardt M et al (2007) Postoperative intravenous morphine consumption, pain scores, and side effects with perioperative oral controlled-release oxycodone after lumbar discectomy. Anesth Analg 105:233–237
Brander V, Gondek S, Martin E et al (2007) Pain and depression influence outcome 5 years after knee replacement surgery. Clin Orthop Relat Res 464:21–26
Caumo W, Schmidt AP, Schneider CN et al (2002) Preoperative predictors of moderate to intense acute postoperative pain in patients undergoing abdominal surgery. Acta Anaesthesiol Scand 46:1265–1271
Cheville A, Chen A, Oster G et al (2001) A randomized trial of controlled-release oxycodone during inpatient rehabilitation following unilateral total knee arthroplasty. J Bone Joint Surg Am 83-A:572–576
de Beer J de V, Winemaker MJ, Donnelly GA et al (2005) Efficacy and safety of controlled-release oxycodone and standard therapies for postoperative pain after knee or hip replacement. Can J Surg 48:277–283
De Cosmo G, Congedo E, Lai C et al (2008) Preoperative psychologic and demographic predictors of pain perception and tramadol consumption using intravenous patient-controlled analgesia. Clin J Pain 24:399–405
Fanelli G, Ghisi D, Berti M et al (2008) Preoperative administration of controlled-release oxycodone as a transition opioid for total intravenous anaesthesia in pain control after laparoscopic cholecystectomy. Surg Endosc 22:2220–2228
Fletcher D, Fermanian C, Mardaye A et al (2008) A patient-based national survey on postoperative pain management in France reveals significant achievements and persistent challenges. Pain 137:441–451
Gerbershagen HJ, Dagtekin O, Rothe T et al (2008) Risk factors for acute and chronic postoperative pain in patients with benign and malignant renal disease after nephrectomy. Eur J Pain 13:853–860
Gerbershagen HJ, Ozgur E, Dagtekin O et al (2009) Preoperative pain as a risk factor for chronic post-surgical pain – six month follow-up after radical prostatectomy. Eur J Pain 13:1054–1061
Gray A, Kehlet H, Bonnet F et al (2005) Predicting postoperative analgesia outcomes: NNT league tables or procedure-specific evidence? Br J Anaesth 94:710–714
Herrmann-Lingen C, Buss U, Snaith RP (2011) Hospital anxiety and depression scale. Deutsche Version (HADS-D), 3. Aufl. Huber, Bern
Hoskin PJ, Hanks GW, Aherne GW et al (1989) The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers. Br J Clin Pharmacol 27:499–505
Ip HY, Abrishami A, Peng PW et al (2009) Predictors of postoperative pain and analgesic consumption: a qualitative systematic review. Anesthesiology 111:657–677
Kalso E (2005) Oxycodone. J Pain Symptom Manage 55:47–56
Katz J, Jackson M, Kavanagh BP et al (1996) Acute pain after thoracic surgery predicts long-term post-thoracotomy pain. Clin J Pain 12:50–55
Kehlet H, Jensen TS, Woolf CJ (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367:1618–1625
Kehlet H, Wilkinson RC, Fischer HB et al (2007) PROSPECT: evidence-based, procedure-specific postoperative pain management. Best Pract Res Clin Anaesthesiol 21:149–159
Macrae WA (2008) Chronic post-surgical pain: 10 years on. Br J Anaesth 101:77–86
Maier C, Nestler N, Richter H et al (2010) The quality of pain management in German hospitals. Dtsch Arztebl Int 107:607–614
McGreevy K, Bottros MM, Raja SN (2011) Preventing chronic pain following acute pain: risk factors, preventive strategies, and their efficacy. Eur J Pain Suppl 5:365–372
Meissner W, Leyendecker P, Mueller-Lissner S et al (2009) A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain 13:56–64
Merskey H, Bogduk N (1994) Classification of chronic pain: descriptions of chronic pain syndromes and definition of pain terms. IASP Press, Seattle
Mucci-LoRusso P, Berman BS, Silberstein PT et al (1998) Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study. Eur J Pain 2:239–249
Peters ML, Sommer M, Rijke JM de et al (2007) Somatic and psychologic predictors of long-term unfavorable outcome after surgical intervention. Ann Surg 245:487–494
Poleshuck EL, Katz J, Andrus CH et al (2006) Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain 7:626–634
Powell AE, Davies HT, Bannister J et al (2004) Rhetoric and reality on acute pain services in the UK: a national postal questionnaire survey. Br J Anaesth 92:689–693
Power I, McCormack J (2007) Postoperative pain management: new, convenient analgesic therapies. Expert Opin Pharmacother 8:391–399
Radbruch L, Loick G, Kiencke P et al (1999) Validation of the German version of the Brief Pain Inventory. J Pain Symptom Manage 18:180–187
Rosenberger PH, Jokl P, Ickovics J (2006) Psychosocial factors and surgical outcome: an evidence based literature review. J Am Acad Orthop Surg 14:397–405
Schnabel A, Pogatzki-Zahn E (2010) Prädiktoren für chronische Schmerzen nach Operationen. Was wissen wir wirklich? Schmerz 24:517–531
Strassels SA, Chen C, Carr DB (2002) Postoperative analgesia: economics, resource use, and patient satisfaction in an urban teaching hospital. Anesth Analg 94:130–137
Tasmuth T, Estlanderb AM, Kalso E (1996) Effect of present pain and mood on memory of past postoperative pain in women treated surgically for breast cancer. Pain 68:343–347
Thomas T, Robinson C, Champion D et al (1998) Prediction and assessment of the severity of postoperative pain and of satisfaction with management. Pain 75:177–185
Wang JJ, Ho ST, Liu YH et al (1999) Dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy. Br J Anaesth 83:772–775
White PF, Kehlet H (2010) Improving postoperative pain management: what are the unresolved issues? Anesthesiology 112:220–225
Wirz S, Nadstawek J, Elsen C et al (2012) Laxative management in ambulatory cancer patients on opioid therapy: a prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose. Eur J Cancer Care 21:131–140
Wu CL, Raja SN (2011) Treatment of acute postoperative pain. Lancet 377:2215–2225
Interessenkonflikt
Die korrespondierende Autorin weist für sich und ihre Koautoren auf folgende Beziehungen hin: E.M. Pogatzki-Zahn: Beratungs- und Vortragstätigkeiten für B. Braun, Mundipharma, MSD, Pfizer, Janssen-Cilag und Grünenthal; P. Zahn: Vortragstätigkeiten für Mundipharma und Mitsubishi Pharma. Die Datenerhebung wurde finanziell z. T. unterstützt durch Mundipharma. Die Firma nahm weder Einfluss auf die Auswertung noch auf die Publikation der Daten.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pogatzki-Zahn, E., Englbrecht, J., Pöpping, D. et al. Oraler Therapiealgorithmus bei akuten postoperativen Schmerzen. Schmerz 27, 26–37 (2013). https://doi.org/10.1007/s00482-012-1279-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00482-012-1279-5
Schlüsselwörter
- Patientenkontrollierte Analgesie
- Opioide
- Retardiertes Oxycodon
- Schmerztherapie
- Chronischer postoperativer Schmerz